Journal Information
Most often read
14061
Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatmentE. Flores-Fernández, I. Vázquez-Gomez, E. Valls-Pascual, C. Valera-Ribera, P. Andújar-Brazal, J.J. Alegre-Sancho
Reumatol Clin. 2023;19:565-70
14061
Full text access
Open Article
13314
The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case reportPatricia Aguilera-Fernandez, María del Carmen Navarro-Saez, Carlos Feijoo-Massó, Enrique Esteve-Valverde, Sonia Calzado Isbert, Tamara Parra Parente
Reumatol Clin. 2023;19:593-5
13314
Open Article
9453
Expert recommendations for the use of apremilast in psoriatic arthritisJuan Carlos Torre Alonso, Raquel Almodóvar González, Carlos Montilla Morales, Jesús Sanz Sanz, Federico Díaz González, Eva Pascual Alfonso, Jordi Gratacós
Reumatol Clin. 2023;19:34-44
9453
Open access
Open Article
8466
The classic triad of Löfgren’s syndrome in imagesRami Qanneta
Reumatol Clin. 2023;19:171-2
8466
Open Article
7995
Comparison of the first and sixth waves of the SARS-COV-2 coronavirus pandemic in patients with immune-mediated diseaseCarmen Lobo Rodríguez, Ana M. López-Calleja, Paloma Morales de los Ríos Luna, Susana Sánchez Vázquez, Ángela Molinero Sampedro, Amparo López-Esteban
Reumatol Clin. 2023;19:507-11
7995
Open Article
5771
Systemic lupus erythematosus myocarditis after COVID-19 vaccinationMiguel Sogbe, Andrés Blanco-Di Matteo, I. Madeleine Di Frisco, Juan Fernando Bastidas, Nahikari Salterain, Juan José Gavira
Reumatol Clin. 2023;19:114-6
5771
Open Article
5580
Systemic lupus erythematosus myocarditis and COVID-19 vaccination: CommentAmnuay Kleebayoon, Viroj Wiwanitkit
Reumatol Clin. 2023;19:349
5580
Open Article
5571
Osteomuscular and autoimmune manifestations of long COVID in MexicoLuis Del Carpio-Orantes, Sergio García-Méndez, Andrés Aguilar-Silva, Álvaro Efrén Munguía-Sereno
Reumatol Clin. 2023;19:530-1
5571
Open Article
5518
Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: CorrespondenceRujittika Mungmunpuntipantip, Viroj Wiwanitkit
Reumatol Clin. 2023;19:119
5518
Open Article
5436
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: commentIsmael Francisco Aomar-Millán, Juan Salvatierra, José Luis Callejas-Rubio, Enrique Raya-Álvarez
Reumatol Clin. 2023;19:120-1
5436
Open Article
5415
Comment to: Teleconsultation of infant rheumatology in COVID-19 timeRami Qanneta
Reumatol Clin. 2023;19:119-20
5415
Open Article
5125
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodologyJavier Narváez, Myriam Aburto, Daniel Seoane-Mato, Gema Bonilla, Orlando Acosta, Gloria Candelas, Esteban Cano-Jiménez, Iván Castellví, ... Claudia Valenzuela
Reumatol Clin. 2023;19:74-81
5125
Open Article
4565
Development of a web tool to calculate the cumulative dose of glucocorticoidsNuria Montero-Pastor, Jesús T. Sánchez-Costa, Mercedes Guerra-Rodríguez, Fernando Sánchez-Alonso, Clara Moriano, Javier Loricera, Federico Díaz-González
Reumatol Clin. 2023;19:1-5
4565
Open Article
4533
Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groupsCésar Díaz-Torné, Maria Antònia Pou, Basilio Rodríguez-Díez, Enriqueta Pujol-Ribera
Reumatol Clin. 2023;19:150-8
4533
Open Article
4120
Vaccination against influenza and pneumococus in patients with rheumatoid arthritisMarco Tobar-Marcillo, Carlos Guerrero-Solís, Guillermo Osmar Pool-Valda, Fedra Irazoque-Palazuelos, Sandra Muñoz-López
Reumatol Clin. 2023;19:49-52
4120
Open Article
3570
SER recommendations for the treatment of uveitisEmma Beltrán Catalán, Noé Brito García, Esperanza Pato Cour, Santiago Muñoz Fernández, Alejandro Gómez Gómez, David Díaz Valle, Marisa Hernández Garfella, Félix Manuel Francisco Hernández, ... Ricardo Blanco
Reumatol Clin. 2023;19:465-77
3570
Open Article
3400
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countriesJ.M. Reyes, M.V. Gutierrez, H. Madariaga, W. Otero, R. Guzman, J. Izquierdo, M. Abello, P. Velez, ... L. Amador
Reumatol Clin. 2023;19:319-27
3400
Full text access
Open Article
3343
Pro-inflammatory cytokines in patients with low back pain: A comparative studyMaroua Slouma, Lobna Kharrat, Aymen Tezegdenti, Leila Metoui, Ezzeddine Ghazouani, Rim Dhahri, Imen Gharsallah, Bassem Louzir
Reumatol Clin. 2023;19:244-8
3343
Open Article
3342
Increased risk of stroke among patients with ankylosing spondylitis: A systematic review and meta-analysisAkshaya Srikanth Bhagavathula, Barry L. Bentley, Benjamin Woolf, Thusharika D. Dissanayaka, Jamal Rahmani
Reumatol Clin. 2023;19:136-42
3342
Open Article